Cell Medica is a cell therapy company working on new techniques to cure human diseases based upon a treatment method called cellular immunotherapy. This technique involves harnessing and enhancing the power of the human immune system to fight disease.
Based on a number of academic studies, there is strong evidence that cellular immunotherapy can be used in a safe and effective manner to treat diseases ranging from infections to cancer.
Cell Medica is both an R&D company developing new forms of cell therapies and a cell production/processing company providing clinical-grade cell formulations to hospitals for the treatment of patients.
About
Cell Medica has a world class team of scientific advisors, an experienced leadership team and strong institutional investors.
Clinical Applications
Our lead application is focused on the treatment of CMV reactivation in patients at high risk of infection following bone marrow transplants.
CMV IMPACT Trial
The CMV~IMPACT Study will investigate the clinical effectiveness of immunoprophylactic adoptive cell therapy for the treatment of CMV reactivation in recovering bone marrow transplant patients.
Science
T cell immunotherapy involves using the power of the human immune system to fight disease.
Contact Us
Our executive office is located in Fitzroy Square in London and our research operations are based at the Royal Free Hospital (Hampstead) in cooperation with UCL.